Sign In
1 Mar 2007 10:40
Ark Therapeutics Group PLC01 March 2007 1 March 2007 Ark Therapeutics Group plc Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6, ArkTherapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that theCompany's capital consists of 165,945,358 ordinary shares with voting rights.This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to the interest in, Ark under the FSA's Disclosure and TransparencyRules. - Ends - This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
PVG.L Regulatory News (PVG)
PVG Share
Price
PVG Share
News
PVG Share
Chat
PVG Share
Trades
PVG
Live RNS
PVG Share
Charts
PVG Broker
Ratings
PVG Directors
Deals
PVG Financial
Diary
PVG
Fundamentals
PVG Short
Positions
PVG
Media
PVG Company
Research
PVG Company
Timeline
PVG.L Information
- There is currently no data for PVG
Voting Rights and Capital
| Date | Source | Headline | |
|---|---|---|---|
| 21st Mar 2005 | 4:29 pm | RNS | Director Shareholding |
| 21st Mar 2005 | 4:21 pm | RNS | Director Shareholding |
| 14th Mar 2005 | 5:55 pm | RNS | Director's Share Dealing |
| 14th Mar 2005 | 5:06 pm | RNS | Director Shareholding |
| 14th Mar 2005 | 5:00 pm | RNS | Director Shareholding |
| 10th Mar 2005 | 7:01 am | RNS | Final Results |
| 21st Jan 2005 | 7:00 am | RNS | Granted Patent |
| 19th Jan 2005 | 4:21 pm | RNS | Interest in Shares |
| 17th Jan 2005 | 7:00 am | RNS | Trading Update |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.
Follow the stocks
